Cargando…
Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder
BACKGROUND: The cost-effectiveness of treatment strategies for patients with Major Depressive Disorder (MDD) who have not responded to two adequate treatments with antidepressants (TRD) are still unclear. The aim of this analysis was to evaluate the cost-effectiveness of add-on repetitive Transcrani...
Autores principales: | Zemplényi, Antal, Józwiak-Hagymásy, Judit, Kovács, Sándor, Erdősi, Dalma, Boncz, Imre, Tényi, Tamás, Osváth, Péter, Voros, Viktor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238085/ https://www.ncbi.nlm.nih.gov/pubmed/35764989 http://dx.doi.org/10.1186/s12888-022-04078-9 |
Ejemplares similares
-
Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta-analysis of randomized sham-controlled trials
por: Vida, Róbert György, et al.
Publicado: (2023) -
Is repetitive Transcranial Magnetic Stimulation really effective in the treatment of major depression? – Results of a Meta-Analysis
por: Kovacs, S., et al.
Publicado: (2022) -
Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?
por: Kovács, Sándor, et al.
Publicado: (2022) -
Crisis Concept Re-loaded?—The Recently Described Suicide-Specific Syndromes May Help to Better Understand Suicidal Behavior and Assess Imminent Suicide Risk More Effectively
por: Voros, Viktor, et al.
Publicado: (2021) -
Untreated depressive symptoms significantly worsen quality of life in old age and may lead to the misdiagnosis of dementia: a cross-sectional study
por: Voros, Viktor, et al.
Publicado: (2020)